In cognitively healthy middle-aged adults at risk for Alzheimer’s disease, becoming physically active, especially in line ...

Company plans to file NDA in the third quarter of this yearBEDFORD, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading ...

A new blood test used to detect the pathology of Alzheimer’s Disease has just launched in Utah, and local experts are calling ...

ARUP Laboratories has introduced a blood test for phosphorylated tau 217 to aid in diagnosing the pathology of Alzheimer's ...

AD pathological markers (Aβ and tau) were assessed using positron emission tomography. Brain parenchymal damage markers ... and clinical dementia rating scale sum of boxes (CDR-SOB). The amyloid PET ...

A research team led by Professor Park Young-ho of the Department of Neurology at Seoul National University Bundang Hospital (Sunchon Hyang University Seoul Hospital Han Sang-won, Professor Pyeon Jeong ...

The validation cohort included blood specimens and results from amyloid positron emission tomography (amyloid-PET) imaging of 524 individuals. "Not only did we have data for the method comparison ...

In recent years, the rapid development of positron emission tomography (PET) molecular imaging has offered new possibilities for noninvasive detection, quantification, and monitoring of cardiac ...